Group 2G: Cell Signaling, Tumor Microenvironment

Thursday, Sept 15
2:00 pm – 3:30 pm Eastern Time (US/New York)

Poster #1: 

Cripto Regulates Heterotypic Signaling and Cell-State in Breast Cancer

Poster author David Freeman will attend this session

Poster #2:

Non-Canonical Wnt/Ror2 Signaling Regulates Tumor Cell Invasion and Dissemination in Breast Cancer Through Cell-Matrix Crosstalk

Poster author Hongjiang Si, Ph.D. may attend this session

Mentor: Silke Pflueger, Ph.D.

Silke Pflueger was initially conscripted to the breast cancer world in 2013 with early HR+/HER2- cancer. In 2019 she discovered that her sciatic pain wasn’t a slipped disk, but a large lesion in her sacrum. Having a scientific background as a PhD in Engineering, and many conferences as an attendee and conference chair she has shifted her focus to learn as much about the disease as she can, helping others with breast cancer to understand treatments and find clinical trials.

Twitter: @silke4senate

Scientist: Vinton Cheng, M.D., Ph.D.

Vinton Cheng is an academic clinical lecturer at the University of Leeds and St James’s University Hospital, UK. He completed his DPhil at the University of Oxford, where he studied a molecularly targeted MRI contrast agent that was shown to improve detection of brain metastasis. Vinton enjoys working at the interface of different research disciplines and most recently spent a year working in the Focused Ultrasound group at the University of Virginia investigating how to enhance the immune response against brain metastasis. He is passionate about communicating science and collaborating with patients in the clinic to improve cancer care